Syndax Pharmaceuticals, Inc.Syndax Pharmaceuticals, Inc.Syndax Pharmaceuticals, Inc.

Syndax Pharmaceuticals, Inc.

No trades
See on Supercharts

SNDX fundamentals

The current financial position of Syndax Pharmaceuticals, Inc.

Total assets of SNDX for Q2 25 is 596.15 M USD, 6.95% less than the previous Q1 25. And total liabilities increased by 3.07% in Q2 25 to 438.73 M USD.

Q3 '17
Q4 '17
Q1 '18
Q2 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Total assets
Total liabilities
Currency: USD
Q3 '17
Q4 '17
Q1 '18
Q2 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Total assetsYoY growth
Total equityYoY growth